tdc-1

Caenorhabditis elegans

Enables tyrosine decarboxylase activity. Involved in octopamine biosynthetic process. Located in axon and neuronal cell body. Expressed in hermaphrodite gonad and lateral ganglion. Human ortholog(s) of this gene implicated in several diseases, including aromatic L-amino acid decarboxylase deficiency; bipolar disorder; and hyperinsulinism. Is an ortholog of human DDC (dopa decarboxylase).

F02A9.8

Caenorhabditis elegans

Is affected by cep-1; fzo-1; and etr-1 based on RNA-seq studies.

W06H8.10

Caenorhabditis elegans

Is affected by cep-1; adr-1; and etr-1 based on RNA-seq studies.

W08D2.11

Caenorhabditis elegans

Is affected by cep-1; hsf-1; and blmp-1 based on RNA-seq studies.

ZK616.62

Caenorhabditis elegans

Is affected by emr-1; cep-1; and adr-1 based on RNA-seq studies.

F26F12.17

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and etr-1 based on RNA-seq studies.

T18H9.10

Caenorhabditis elegans

Is affected by cep-1; adr-1; and dlc-1 based on RNA-seq studies.

Y73B6A.16

Caenorhabditis elegans

Is affected by adr-1; fzo-1; and camt-1 based on RNA-seq studies.

CD4.18

Caenorhabditis elegans

Is affected by skn-1; sftb-1; and car-1 based on RNA-seq studies.

F26F12.15

Caenorhabditis elegans

Is affected by pgrn-1; dlc-1; and etr-1 based on RNA-seq studies.